Clinically Meaningful Improvement in Physical Fatigue and Muscle Weakness Fatigability with Rozanolixizumab: Post-hoc Analysis of MG Symptoms PRO Responder Rate in the MycarinG study (P4-11.001)
Ali A Habib, Henry J Kaminski, Julian Grosskreutz, Renato Mantegazza, Tuan Vu, John Vissing, Marion Boehnlein, Bernhard Greve, Fiona Grimson, Asha Hareendran, Vera Bril
Dive into the research topics of 'Clinically Meaningful Improvement in Physical Fatigue and Muscle Weakness Fatigability with Rozanolixizumab: Post-hoc Analysis of MG Symptoms PRO Responder Rate in the MycarinG study (P4-11.001)'. Together they form a unique fingerprint.